Pharmaceutical Headlines for 31 may 2011 ( Tuesday ) !

AVEO Pharmaceuticals, Inc. (AVEO) Enters into Worldwide License Agreement with Centocor Ortho Biotech Inc.; AVEO Receives $15 Million; Eligible for up to $540 Million More...




AstraZeneca PLC (AZN), Heptares In Study Pact Targeting GPCR Drugs;Heptares to Receive $6.25 Million Upfront More...



Generex Biotechnology Corporation (GNBT) in Agreement to License RapidMist(TM) Technology for $10 Million to Amarantus BioSciences for Use With Its Proprietary MANF Proteins More...


Deinove Achieves The First Key Milestone In The Deinol Project And Receives E1.6 Million From OSEO More...


SAIC-Frederick, Inc. (SAI) and Biomatrica Collaborate to Improve Molecular Analysis in Cancer Research More...

Future Bleak for Renovo Group Plc (RNVO.L) With No Workers or Products More...


JB Chemicals & Pharmaceuticals Limited to Hire About 800 Medical Representatives in 2 Years More...




Intrexon Corporation Raises $100 Million for Synthetic Biology InitiativesMore...


Excelimmune, Inc. Completes $10.5 Million Series B Financing More...


EpiCept Corporation (EPCT) Obtains New $10.6 Million Secured Debt Financing More...

Ashland to Acquire International Specialty Products More...

• A New Chief Executive Officer to Strengthen BioAlliance Pharma's Growth More...


Segal Institute for Clinical Research Announces Appointment of Dr. Leslie Penny Moldauer as Corporate Chief Medical Officer More...


Enzo Biochem (ENZ) Names Ana I. Stancic Chief Financial Officer More...


Peregrine Pharmaceuticals, Inc. (PPHM) Appoints Jeffrey Masten as Vice President, Quality as Company Advances Phase II Clinical Programs More...


Derycz Scientific Hires AstraZeneca PLC (AZN) Executive to Drive Global Sales Growth More...

Acasti Pharma Year End Results More...


Medicago, Inc. Announces 2011 First Quarter Results More...

Triclinic Labs Adds New Laboratory Space and Chemical Development Capabilities More...

Sanofi (France) (SASY.PA)'s Diabetes Drug Cuts Blood Sugar, Weight-Study More... 

Eli Lilly and Company (LLY) Presents Data on Cixutumumab in Five Subtypes of Sarcomas More... 

UCB Group (UCBJF.PK) Release: New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V More... 

Aegerion Pharmaceuticals, Inc. Announces Phase III 56-Week Data in HoFH Patients Taking Investigational Lomitapide is Consistent With 26-Week Data More... 

Teva Pharmaceutical Industries Limited (TEVA) Announces Data on Granulocyte Colony Stimulating Factor Compounds for the Prevention of Chemotherapy-Induced Neutropenia in Breast Cancer Patients More...

• FDA Approves Optimer Pharmaceuticals, Inc. (OPTR)'s Dificid, a Treatment For Clostridium Difficile Infection More... 

• FDA Approves Oceana Therapeutics's Solesta(R); Novel Specialty Therapeutic Addresses Large Treatment Void for Patients with Life-Altering Fecal (Bowel) Incontinence More...

Affymax, Inc. (AFFY) and Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Announce the Submission of a New Drug Application for Peginesatide for the Treatment of Anemia Associated with Chronic Renal Failure in Patients on Dialysis More...

• No Link Between Stress and MS in Women, According to University of Bergen Study More... 

• Combo of Paxil, Pravachol May Raise Blood Sugar, Stanford University Study More... 

• Bacteria Police Keep Cheaters in Line, Proceedings of the National Academy of Sciences Study More... 

• Drug Can Reverse Overgrown Hearts to Help Prevent Heart Failure, UT Southwestern Medical Center Researchers Find More... 

• Mutated Muscle Protein Causes Deafness, Max Planck Institute Research More...

( Source: Biospace )
Tags: ,

About author

Make it happen !!

0 comments

Leave a Reply